Applied UV Declares Monthly Preferred Stock Dividend
25 January 2023 - 12:00AM
Business Wire
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically, today
announced its Board of Directors has authorized the cash dividend
to holders of Applied UV’s 10.5% Series A Cumulative Perpetual
Preferred Stock.
Holders of the 10.5% Series A Cumulative Perpetual Preferred
Stock (Nasdaq: AUVIP) shall receive a cash dividend equal to
$0.21875 per share.
The return of capital will be paid on or about February 15,
2023, to respective holders of record at the close of business on
February 3, 2023.
About Applied UV
Applied UV, Inc. (“AUVI”) develops and acquires proprietary
infection prevention and control technology in the healthcare,
commercial & public venues, food transportation/storage,
cannabis and education vertical markets. The Company has two wholly
owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn
Works, LLC (“Munn Works”). Sterilumen owns and markets a portfolio
of products with advanced pathogen elimination technology, branded
Airocide® by Sterilumen, Scientific Air™ by Sterilumen, Airoclean™
420 by Sterilumen, and Lumicide™ by Sterilumen.
Leading organizations globally rely on AUVI’s air purification
systems to completely eliminate airborne and surface infections,
mold, bacteria, allergens and other contaminants. Our customers
include Kaiser Permanente, NY Health+Hospitals, Baptist Health
South Florida, Boston Red Sox’s Fenway Park, JetBlue Park, France’s
Palace of Versailles, Invited Clubs, Whole Foods, Del Monte Foods,
U.S. Department of Veterans Affairs, and more.
NASA used Airocide’s proprietary Photocatalytic Oxidation
technology to sanitize the International Space Station.
Scientifically proven to reduce Healthcare Acquired Infections
(HAI), Scientific Air™ offers a proprietary 3-stage technology
integrating HEPA filters, ultraviolet germicidal light chamber and
active carbon substrate.
For information on Applied UV, Inc., and its subsidiaries,
please visit the following websites: https://www.applieduvinc.com/
https://www.sterilumen.com https://airoclean420.com/
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230124005124/en/
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Mar 2024 to Mar 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Mar 2023 to Mar 2024